About Mirabio Biotech
Mirabio Biotech is a next-generation biotech company dedicated to extending human healthspan by integrating regenerative medicine, integrative healthcare, and advanced biological innovation into a modern holistic platform.
Cellular deterioration is influenced by systemic biological factors — particularly blood environment and intercellular signaling. By optimizing these systems, we promote measurable biological rejuvenation.
Where regenerative medicine meets personalized innovation to advance human health and longevity.
We strive to revolutionize healthcare by developing science-driven solutions that enhance cellular vitality, prevent age-related decline, and support sustainable well-being.
Mirabio unites regenerative medicine, traditional healing wisdom, and advanced biotechnology into a single ecosystem focused on prevention, restoration, and performance optimization.
Our commitment is to deliver personalized, effective, and future-focused healthcare for individuals and communities worldwide.
Mirafarma (M) Sdn. Bhd. was established, focusing on cosmeceutical innovation and early exploration of regenerative biotechnology.
Expansion into MSC-based regenerative products introduced modern regenerative concepts to local practitioners.
Pioneering 3D-printed facial mask technology and AI-driven analysis through the MIRA Facebank platform.
Introduction of PX-100 Young Plasma Conditioning, advancing personalized biologics in regenerative therapy.
Company rebranded as Mirabio Biotech, evolving into a comprehensive longevity platform.
Launch of Bita-Labo and strategic CDMO partnerships strengthening international presence.
We envision a future where aging is understood, optimized, and transformed through advanced biotechnology.
Mirabio is committed to leading the next era of regenerative healthcare and longevity science.
